[go: up one dir, main page]

TNSN88013A1 - Interleukine - 3 humaine et ses muteines - Google Patents

Interleukine - 3 humaine et ses muteines

Info

Publication number
TNSN88013A1
TNSN88013A1 TNTNSN88013A TNSN88013A TNSN88013A1 TN SN88013 A1 TNSN88013 A1 TN SN88013A1 TN TNSN88013 A TNTNSN88013 A TN TNSN88013A TN SN88013 A TNSN88013 A TN SN88013A TN SN88013 A1 TNSN88013 A1 TN SN88013A1
Authority
TN
Tunisia
Prior art keywords
muteins
human
interleukine
nucleic acids
acids encoding
Prior art date
Application number
TNTNSN88013A
Other languages
English (en)
Inventor
Otsuka Takeshi
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of TNSN88013A1 publication Critical patent/TNSN88013A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CETTE INVENTION CONCERNE DES MEDIATEURS PROTEINES DU DEVELOPPEMENT DU SYSTEME HEMATOPOIETIQUE AINSI QU'AUX ACIDES NUCLEIQUES LES CODANT. PLUS PARTICULIEREMENT, L'INVENTION SE RAPPORTE A UNE VARIANTE DE L'INTERLEUKINE-3 HUMAINE, A SES MUTEINES ET AUX ACIDES NUCLEIQUES LES CODANT.
TNTNSN88013A 1987-02-18 1988-02-17 Interleukine - 3 humaine et ses muteines TNSN88013A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1607987A 1987-02-18 1987-02-18

Publications (1)

Publication Number Publication Date
TNSN88013A1 true TNSN88013A1 (fr) 1990-07-10

Family

ID=21775278

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN88013A TNSN88013A1 (fr) 1987-02-18 1988-02-17 Interleukine - 3 humaine et ses muteines

Country Status (16)

Country Link
EP (2) EP0282185A1 (fr)
JP (1) JPH02500328A (fr)
KR (1) KR890700608A (fr)
CN (1) CN88100685A (fr)
AR (1) AR243240A1 (fr)
AU (1) AU626789B2 (fr)
FI (1) FI893872A7 (fr)
HU (1) HU204890B (fr)
IL (1) IL85444A0 (fr)
MY (1) MY102806A (fr)
NZ (1) NZ223551A (fr)
OA (1) OA09736A (fr)
PT (1) PT86772B (fr)
TN (1) TNSN88013A1 (fr)
WO (1) WO1988006161A1 (fr)
ZA (1) ZA881109B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
AU1496688A (en) * 1987-01-20 1988-08-10 Immunex Corporation Human interleukin-3 proteins
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
WO1990001039A1 (fr) * 1988-07-20 1990-02-08 Immunex Corporation Compositions d'interleukine-3 humaine non glycosylee
US5128450A (en) * 1989-06-30 1992-07-07 Urdal David L Nonglycosylated human interleukin-3 analog proteins
ATE154638T1 (de) * 1989-08-14 1997-07-15 Gist Brocades Nv Mutanten von interleukin-3
US5516512A (en) 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
US5108910A (en) * 1989-08-22 1992-04-28 Immunex Corporation DNA sequences encoding fusion proteins comprising GM-CSF and IL-3
DK0489116T3 (da) * 1989-08-22 1994-05-02 Immunex Corp Fusionsproteiner omfattende GM-CSF og IL-3
US5073627A (en) * 1989-08-22 1991-12-17 Immunex Corporation Fusion proteins comprising GM-CSF and IL-3
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
JPH07501520A (ja) * 1991-10-07 1995-02-16 メドベット　サイエンス　プロプライエタリー　リミテッド ヒトｉｌ−３変種
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
ATE251669T1 (de) * 1992-11-24 2003-10-15 Searle & Co Mutierte polypeptide des interleukin-3(il-3)
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
WO1997012633A1 (fr) 1995-10-04 1997-04-10 Immunex Corporation Facteur de stimulation de cellules dendritiques
WO2001034648A1 (fr) 1999-11-12 2001-05-17 Baxter International, Inc. Compositions d"hemoglobine a effets secondaires reduits
WO2006079169A1 (fr) * 2005-01-25 2006-08-03 Apollo Life Sciences Limited Gm-csf, il-3, il-4, il-5 choisis en fonction de parametres et leurs chimeres dans des applications therapeutiques et diagnostiques
US9821114B2 (en) 2012-02-07 2017-11-21 Global Bio Therapeutics, Inc. Compartmentalized method of nucleic acid delivery and compositions and uses thereof
WO2015021443A1 (fr) 2013-08-08 2015-02-12 Global Bio Therapeutics Usa, Inc. Dispositif de serrage pour procédures mini-invasives et utilisations de ce dernier
CN112195177B (zh) * 2020-10-28 2021-08-06 上海慕柏生物医学科技有限公司 一种核酸提取方法及试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60207594A (ja) * 1984-03-30 1985-10-19 Ajinomoto Co Inc ヒトインタ−ロイキン３の製造方法
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
AU617095B2 (en) * 1986-12-16 1991-11-21 Dsm N.V. Molecular cloning and expression of human il-3

Also Published As

Publication number Publication date
ZA881109B (en) 1988-08-17
AR243240A1 (es) 1993-07-30
HUT50872A (en) 1990-03-28
PT86772A (pt) 1988-03-01
EP0355093A1 (fr) 1990-02-28
AU1429488A (en) 1988-09-14
PT86772B (pt) 1992-05-29
AU626789B2 (en) 1992-08-13
JPH02500328A (ja) 1990-02-08
WO1988006161A1 (fr) 1988-08-25
HU204890B (en) 1992-02-28
OA09736A (en) 1993-11-30
KR890700608A (ko) 1989-04-26
NZ223551A (en) 1991-02-26
IL85444A0 (en) 1988-07-31
CN88100685A (zh) 1988-12-14
MY102806A (en) 1992-11-30
FI893872A0 (fi) 1989-08-17
EP0282185A1 (fr) 1988-09-14
FI893872A7 (fi) 1989-08-17

Similar Documents

Publication Publication Date Title
TNSN88013A1 (fr) Interleukine - 3 humaine et ses muteines
ES2102196T3 (es) Periferializacion de celulas pluripotenciales hematopoyeticas.
DE69435049D1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
FI864654A0 (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
HU9602313D0 (en) Antibody purification
NO982062D0 (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav
AU1352483A (en) Functional human urokinase proteins
ATE125269T1 (de) Radiomarkierte peptide mit antikoagulanswirkung.
WO2003103585A3 (fr) Methodes de traitement de l'angiogenese, de la croissance tumorale et de metastases
BG49827A3 (bg) Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор
BG101832A (en) Methods and materials for attributing plant resistance to diseases
IL93756A (en) Purification of recombinant human interleukin-3 and muteins thereof
DE69333412D1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
IT1270618B (it) Proteine ad attivita' antitumorale
DE3855080D1 (de) Synoviale phospholipasen
DE69333497D1 (de) Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten
ES2111757T3 (es) Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos.
EP0495910A4 (en) Production and use of human nm23 protein and antibodies therefor
ATE191923T1 (de) Interleukine-6 mutante mit verbesserter biologischer aktivität im vergleich zu wildtyp il-6
ATE249837T1 (de) Caspase 8-inhibitoren zur immunsuppression
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
NO962596L (no) Nytt tumorsupressorgen
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
LV10199A (lv) Neglikozileta proteina farmaceitiskais preparats un ta iegusanas panemiens